Shijiazhuang, February 17 (Reporter Bu Yan) Inheriting and innovating the development of traditional Chinese medicine is an important part of the cause of socialism with Chinese characteristics in the new era, and is the ardent expectation of the party and the people. In recent years, Ling Pharmaceutical has always taken the inheritance and innovation of traditional Chinese medicine as its own responsibility, developed more than 10 innovative traditional Chinese medicines covering a number of common diseases, and made continuous breakthroughs in scientific research platforms, talent use, industrial layout, etc., and won six national science and technology awards such as the first prize of the National Science and Technology Progress Award, covering theoretical innovation, technological innovation, application achievements, etc., and promoted the modernization, industrialization and internationalization of traditional Chinese medicine.
Yiling Pharmaceutical has won six national science and technology awards (courtesy of Yiling Pharmaceutical)
The depth of scientific research investment and the layout of talent echelons
In the past 30 years since its establishment, Yiling Pharmaceutical has always taken "inheriting innovation and benefiting mankind" as its corporate purpose, and has accelerated the pace of scientific research and innovation after achieving a series of achievements such as six national awards, and has continued to exert efforts from many sectors such as traditional Chinese medicine anti-aging, cardiovascular and cerebrovascular diseases, respiratory health, and chemical biologics, and has achieved a number of breakthrough results and solved one problem after another in the medical community.
Finding effective intervention strategies and drugs for the prevention and treatment of Progeria and related diseases is a difficulty, hot spot and focus of international medical development. Yiling Pharmaceutical has built the most advanced anti-aging research and development platform in China. The person in charge of the platform is mainly returned doctors and graduate students, with strong technical strength of talents, experimental equipment in line with international standards, with a total investment of more than 50 million yuan, including molecular biology laboratories, cell workstations, sub-animal workstations, electrophysiological function laboratories, etc. "Under the guidance of 'Network Disease Theory', this platform uses the existing systems biology theory to expound the theoretical basis and guiding value of the vein theory and the air network theory in brain aging, vascular aging, respiratory aging and immune aging, etc., and promotes the systematic cognition of aging and the discovery of interventionable targets, and ultimately realizes the treatment of aging-related diseases." Dr. Hou Yunlong, the person in charge of the platform, introduced it.
"Poof..." As a small popper exploded inside the mask, a fragrant mint smell came to the nose, the discomfort of wearing the mask disappeared, and the mind instantly became clear...
This magical "mask companion" is a lianhua mask popball developed by Ling Pharmaceutical's "multidisciplinary interdisciplinary innovation team for lung network disease prevention and control research", and is also one of the lianhua respiratory health series products, the main ingredient of which is lianhua antibacterial and bacteriostatic essential oil extracted from the Lianhua Qing plague formula.
Based on the series of "internal adjustment" products developed by lianhua qingbi group, including lianhua qingfei plant drink, lianhua ancient tea, honeysuckle black tea, and "nourishing body deficiency" lianhua yuping herbal dietary supplement. These two series form a comprehensive prevention and control strategy of "external prevention and internal adjustment", which constitutes the overall solution for respiratory health.
Yiling Pharmaceutical Lianhua Respiratory Health Series Products (Courtesy of Yiling Pharmaceutical)
The reason why Yiling Pharmaceutical continues to export innovative patented drugs depends on its perfect scientific research platform and high-end talents. Hebei Yiling Pharmaceutical Research Institute is a scientific research base of Yiling Pharmaceutical, and has successively created state-level scientific research platforms such as the State Key Laboratory of Disease Research and Innovation in Traditional Chinese Medicine and the Key Research Office of the State Administration of Traditional Chinese Medicine (Cardiovascular and Cerebrovascular Disease), presided over more than 90 national, provincial and ministerial projects including the national key research and development plan, "973" and "863", and trained and introduced more than 1,000 R&D talents such as doctoral students and returnees.
In terms of traditional Chinese medicine research and development, in addition to more than 10 innovative patented traditional Chinese medicines that have been listed, Ling Pharmaceutical has accelerated the pace of scientific research," said Wei Cong, president of the Traditional Chinese Medicine Branch of Hebei Yiling Pharmaceutical Research Institute, which covers the cardiovascular system, nervous system, respiratory system, endocrine metabolic system, digestive system, gynecology, pediatrics and other disease fields, at different stages of research, and new drug research and development has formed a multi-field product matrix to continuously meet market demand" said Wei Cong, president of the Chinese Medicine Branch of Hebei Yiling Pharmaceutical Research Institute.
Systematic theoretical innovation of TCM network disease
The theoretical innovation of network disease is the core competitiveness of Ling Pharmaceutical, and a series of innovative Chinese medicine research and development are completed under the guidance of this theory.
Network disease is a disease state that is widely present in a variety of internal injuries and severe external infections. Historically, medical masterpieces such as the Yellow Emperor's Inner Classic, The Treatise on Typhoid Fever and Miscellaneous Diseases, and medical masters such as Ye Tianshi have mentioned the theory of network pulse and network disease, but there has been no systematic in-depth study, nor has it formed a complete theoretical system.
Yiling Pharmaceutical is committed to the theoretical discussion and clinical application research of the theory of network disease, and puts forward the biological theoretical framework of "three-dimensional three-dimensional network system", taking this as the starting point to systematically study the physiological function of the network pulse and the pathogenesis, pathogenesis, dialectic and treatment of network disease, put forward the treatment of network disease syndrome, organ disease and organ related network disease, first established the "network disease treatment" system, established the clinical dialectical treatment method of traditional Chinese medicine for cardiovascular and cerebrovascular diseases, tumors, diabetes and their complications, influenza and other diseases called network disease by ancients, and published the monograph "Network Disease" It has constructed a vein theory guiding the prevention and treatment of vascular lesions, opened up an effective new way for the treatment of vascular lesions through the network, published a monograph on "Vein Theory", and won the second prize of the National Science and Technology Progress Award for "Network Disease Theory and Its Application Research".
A modern research path of Traditional Chinese medicine in line with international standards
"Internationalization" is one of the important strategies for the development of Ling Pharmaceutical, the key difficulty of Chinese medicine to the world is that clinical efficacy and safety are difficult to obtain international recognition, in order to break through the "bottleneck" of Chinese medicine going abroad, Yiling Pharmaceutical has carried out extensive cooperation with many international medical research institutions such as Cardiff University in the United Kingdom, Leiden University in the Netherlands, and Harvard University Medical Heart Research Center, and has carried out extensive cooperation on tongluo prescription drugs, and has achieved a large number of scientific research results.
Duke University in the United States and medical institutions in South Korea, Vietnam, Singapore and other countries joined the national key research and development program "Research on the Intervention of Cardiovascular Event Chains in the Context Theory Guiding System" hosted by Ling Pharmaceutical.
Cooperate with the Heart Research Center of Harvard Medical School in the United States to carry out experimental and clinical research on amaranth to strengthen the heart capsule, and cooperate with Duke University in the United States to carry out the national key research and development program sub-project "Chinese cardiac network treatment of acute myocardial infarction myocardial protection research".
The "Joint Study on the Treatment of Chronic Heart Failure with Compound Chinese Medicine Amaranth Qiangxin Capsules" cooperated with Leiden University in the Netherlands was included in the international scientific and technological cooperation project of the Key Research and Development Program of the Science and Technology Department of Hebei Province, and cooperated in the fields of cardiovascular diseases and infectious diseases. The "University of Mississippi- Yiling Institute of Natural Medicine" established with the University of Mississippi has carried out in-depth cooperation around the clinical center of traditional Chinese medicine and new product research and development.
The project "Research on the Protective Effect of Cardiac Networks on the Cardiovascular System and molecular mechanisms" carried out with Baylor College of Medicine in Texas, USA was included in the International Science and Technology Cooperation Program of the Ministry of Science and Technology.
In addition to the direct establishment of scientific research cooperation institutions with the international community, a number of evidence-based medical research achievements carried out by Yiling Pharmaceutical in China have also been affirmed by the international medical community.
Inheriting and innovating traditional Chinese medicine has a long way to go, as a leading enterprise in the traditional Chinese medicine industry, Yiling Pharmaceutical will continue to exert its scientific research advantages, shoulder the major mission of promoting the culture of traditional Chinese medicine, and constantly develop good drugs that the people urgently need, so that the charm of traditional Chinese medicine can benefit the world!